What are the major opportunities in the Menveo market? What are the strategies for the Menveo market?

For detailed insights on the major opportunities and strategies in the Menveo market, Read More

How does the Menveo market relate to the overall economy and other similar markets?

For detailed insights on Menveo's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Menveo industry?

For detailed insights on the mergers and acquisitions in the Menveo industry, Read More

What are the key dynamics influencing the Menveo market growth? SWOT analysis of the Menveo market.

For detailed insights on the key dynamics influencing the Menveo market growth and SWOT analysis of the Menveo industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Menveo Global Market Report 2025

Name: Menveo Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type of Vaccine (Conjugate Vaccine, Combination Vaccine), By Indication (Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination), By Age Group (Infants and Young Children, Adolescents, Adults, Older Adults), By End User (Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Menveo Market?

Menveo is a vaccines-global-market-report" target="_blank">meningococcal vaccine that protects against infections caused by Neisseria meningitidis. It targets serogroups A, C, W, and Y, which can cause meningitis and bloodstream infections. The vaccine is recommended for adolescents, young adults, and individuals at higher risk of meningococcal disease.

The main vaccine types of menveo are conjugate vaccine and combination vaccine. A conjugate vaccine combines a bacterial protein with a polysaccharide (sugar molecule) to enhance the immune response. This combination helps the immune system recognize and attack the bacteria more effectively. It is indicated for various purposes, including meningococcal disease prevention, routine immunization, outbreak control, and travel vaccination. Menveo is used for different age groups, including infants and young children, adolescents, adults, and older adults. The end users include hospitals, vaccination clinics, travel clinics, academic and research institutions, and military and government facilities.

Menveo Market Size and growth rate 2025 to 2029: Graph

What Is The Menveo Market Size 2025 And Growth Rate?

The menveo market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to public immunization programs, high meningococcal disease burden, strong healthcare infrastructure, international travel requirements, and military vaccination mandates.

What Is The Menveo Market Growth Forecast?

The menveo market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to population growth, rising healthcare awareness, increasing travel, growing school vaccine requirements, and emerging markets expansion. Major trends in the forecast period include rise in combination vaccines, focus on booster doses, increasing demand in emerging economies, enhanced cold chain distribution, and partnerships for market penetration.

Book your 30 minutes free consultation with our research experts

How Is The Menveo Market Segmented?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Is Driving The Menveo Market? Increase In Meningitis Cases Fueling Demand For Menveo Vaccine

The increasing prevalence of meningitis is expected to propel the growth of the menveo market going forward. Meningitis is an infection that causes inflammation of the protective membranes (meninges) surrounding the brain and spinal cord. It can be caused by various factors, including viral, bacterial, or fungal infections. Additionally, antibiotic resistance, weakened immune systems, and global mobility contribute to the spread of the disease. Menveo, a meningococcal vaccine, helps reduce the prevalence of meningitis by protecting against several strains of Neisseria meningitides, a leading cause of bacterial meningitis. Its widespread use in vaccination programs helps prevent outbreaks and reduce disease transmission. For instance, in August 2024, according to the UK Health Security Agency, a UK-based government agency, the meningococcal reference unit (MRU) confirmed 396 cases of invasive meningococcal disease (IMD) from 2022 to 2023, a significant increase from the 205 cases reported in 2021 to 2022. Therefore, the increasing prevalence of meningitis is driving the growth of the menveo market.

What Is Driving The Menveo Market? Impact Of Global Healthcare Infrastructure Expansion On Market Growth

The global expansion of healthcare infrastructure is expected to propel the growth of the menveo going forward. Healthcare infrastructure refers to the physical and organizational structures, facilities, resources, and systems necessary for delivering healthcare services to a population. Several key factors, including the aging global population, the increase in chronic diseases, and technological advancements, drive healthcare infrastructure expansion. Menveo is a meningococcal vaccine that protects patients from invasive meningococcal disease, leveraging healthcare infrastructure through vaccination programs in clinics, hospitals, and public health initiatives. For instance, in September 2024, according to the statistics published by Cross River Therapy, a US-based provider of applied behavior analysis therapy services, the US pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021, and projected spending is expected to increase to $605-$635 billion by 2025. Therefore, the global expansion of healthcare infrastructure is driving the growth of the menveo market.

Who Are The Major Players In The Global Menveo Market?

Major companies operating in the menveo market include GlaxoSmithKline (GSK) Plc

What Are The Key Trends Of The Global Menveo Market? Innovative Vaccine Formulations Driving Market Trends

The key trend in the menveo market is developing innovative vaccine formulations, such as single-vial, fully liquid formulations, to enhance convenience, improve stability, and simplify vaccine administration. Single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and packaged in a single vial, with the active ingredients dissolved in a liquid form, ready for administration. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, received approval from the European Commission (EC) for a new presentation of its meningococcal vaccine, Menveo for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now licensed for use in children aged two years and older, adolescents, and adults. The key features of the approval for the vaccine include its licensing for active immunization in the European Union for children from two years of age, adolescents, and adults, with a new single-vial, fully liquid presentation that eliminates the need for reconstitution before use.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Menveo Market

North America was the largest region in the menveo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the menveo market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Menveo Market?

The menveo market consists of sales of prefilled syringes, powders for suspension, combination vaccines, booster doses, and single-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Menveo Industry?

The menveo market research report is one of a series of new reports from The Business Research Company that provides menveo market statistics, including the menveo industry's global market size, regional shares, competitors with a menveo market share, detailed menveo market segments, market trends and opportunities, and any further data you may need to thrive in the menveo industry. This menveo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Menveo Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine 2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination 3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults 4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline (GSK) Plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Menveo Market Characteristics

3. Menveo Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Menveo Market Trends And Strategies

5. Menveo Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Menveo Growth Analysis And Strategic Analysis Framework

6.1. Global Menveo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Menveo Market Growth Rate Analysis

6.4. Global Menveo Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Menveo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Menveo Total Addressable Market (TAM)

7. Global Menveo Pricing Analysis & Forecasts

8. Menveo Market Segmentation

8.1. Global Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Conjugate Vaccine

Combination Vaccine

8.2. Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Meningococcal Disease Prevention

Routine Immunization

Outbreak Control

Travel Vaccination

8.3. Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Infants and Young Children

Adolescents

Adults

Older Adults

8.4. Global Menveo Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Vaccination Clinics

Travel Clinics

Academic And Research Institutions

Military And Government Facilities

9. Global Menveo Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Menveo Market Regional And Country Analysis

10.1. Global Menveo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Menveo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Menveo Market

11.1. Asia-Pacific Menveo Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Menveo Market

12.1. China Menveo Market Overview

12.2. China Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Menveo Market

13.1. India Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Menveo Market

14.1. Japan Menveo Market Overview

14.2. Japan Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Menveo Market

15.1. Australia Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Menveo Market

16.1. South Korea Menveo Market Overview

16.2. South Korea Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Menveo Market

17.1. Western Europe Menveo Market Overview

17.2. Western Europe Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Menveo Market

18.1. UK Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Menveo Market

19.1. Germany Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Menveo Market

20.1. France Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Menveo Market

21.1. Eastern Europe Menveo Market Overview

21.2. Eastern Europe Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Menveo Market

22.1. North America Menveo Market Overview

22.2. North America Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Menveo Market

23.1. USA Menveo Market Overview

23.2. USA Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Menveo Market

24.1. Canada Menveo Market Overview

24.2. Canada Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Menveo Market

25.1. South America Menveo Market Overview

25.2. South America Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Menveo Market

26.1. Middle East Menveo Market Overview

26.2. Middle East Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Menveo Market

27.1. Africa Menveo Market Overview

27.2. Africa Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Menveo Market Competitive Landscape And Company Profiles

28.1. Menveo Market Competitive Landscape

28.2. Menveo Market Company Profiles

28.2.1. GlaxoSmithKline (GSK) Plc Overview, Products and Services, Strategy and Financial Analysis

29. Global Menveo Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Menveo Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Menveo Market

32. Recent Developments In The Menveo Market

33. Menveo Market High Potential Countries, Segments and Strategies

33.1 Menveo Market In 2029 - Countries Offering Most New Opportunities

33.2 Menveo Market In 2029 - Segments Offering Most New Opportunities

33.3 Menveo Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Menveo Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Menveo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Menveo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: GlaxoSmithKline (GSK) Plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Menveo Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Menveo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Menveo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Menveo Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Menveo Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Menveo Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: GlaxoSmithKline (GSK) Plc Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

Frequently Asked Questions

What is the definition of the Menveo market?

Menveo is a meningococcal vaccine that protects against infections caused by Neisseria meningitidis. It targets serogroups A, C, W, and Y, which can cause meningitis and bloodstream infections. The vaccine is recommended for adolescents, young adults, and individuals at higher risk of meningococcal disease. For further insights on the Menveo market, request a sample here

How will the Menveo market drivers and restraints affect the market dynamics? What forces will shape the Menveo industry going forward?

The Menveo market major growth driver - Increase In Meningitis Cases Fueling Demand For Menveo Vaccine. For further insights on the Menveo market, request a sample here

What is the forecast market size or the forecast market value of the Menveo market?

The Menveo market size has grown strongly in recent years. The menveo market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to public immunization programs, high meningococcal disease burden, strong healthcare infrastructure, international travel requirements, and military vaccination mandates. The menveo market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to population growth, rising healthcare awareness, increasing travel, growing school vaccine requirements, and emerging markets expansion. Major trends in the forecast period include rise in combination vaccines, focus on booster doses, increasing demand in emerging economies, enhanced cold chain distribution, and partnerships for market penetration. For further insights on the Menveo market, request a sample here

How is the Menveo market segmented?

The menveo market covered in this report is segmented –
1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine
2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination
3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults
4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities For further insights on the Menveo market, request a sample here

Which region has the largest share of the Menveo market? What are the other regions covered in the report?

Who are the major players in the Menveo market?

Major companies operating in the menveo market include GlaxoSmithKline (GSK) Plc . For further insights on the Menveo market, request a sample here.

What are the key trends in the Menveo market?

Major trends in the Menveo market include Innovative Vaccine Formulations Driving Market Trends. For further insights on the Menveo market, request a sample here.